Operating Income: The income after operating expenses.
Werewolf Therapeutics, Inc. (HOWL) had Operating Income of $-9.42M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.38M |
|
-- |
|
-- |
|
$9.42M |
|
|
Operating Income |
$-9.42M |
$1.04M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-9.42M |
|
$-9.02M |
|
46.02M |
|
46.81M |
|
$-0.16 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$58.59M |
|
$4.69M |
|
$10.81M |
|
$69.40M |
|
$36.15M |
|
-- |
|
$8.44M |
|
$44.59M |
|
$24.80M |
|
$24.80M |
|
$24.80M |
|
48.60M |
|
| Cash Flow Statement Financials | |
$-60.29M |
|
-- |
|
$6.03M |
|
$112.22M |
|
$57.95M |
|
$-54.26M |
|
$6.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
-- |
|
1.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.79% |
|
-33.79% |
|
-12.08% |
|
-33.79% |
|
$0.51 |
|
$-1.29 |
|
$-1.29 |
|